O18 - EXCELLENT TRANSPLANT OUTCOMES WITH FLUDARABINE-TREOSULFAN (FT) REDUCED-TOXICITY CONDITIONING (RTC) IN COMBINATION WITH DUALT-CELL DEPLETION (TCD) IN MYELOABLATIVE CONDITIONING (MAC)-INELIGIBLE PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)

Autor: Pasic, I., Remberger, M., Chen, C., Gerbitz, A., Kim, D., Kumar, R., Lam, W., Law, A., Lipton, J., Michelis, F., Novitzky-Basso, I., Viswabandya, A., Mattsson, J.
Zdroj: In Leukemia Research May 2023 128 Supplement
Databáze: ScienceDirect